|
Human-Enzyme Mediated, Depletion of Homocysteine for Treating Patients with Homocysteinemia/Homocystinuria
This technology uses engineered human enzymes with enhanced activity to efficiently break down toxic homocysteine, offering improved treatment for metabolic disorders like homocystinuria and hyperhomocysteinemia through enzyme therapy, gene therapy, or pharmaceutical formulations.
Background
Homocystinuria and hyperhomocysteinemia are inherited or...
|
|
Non-invasive sono-optogenetic platform for deep brain neural modulation
Background
Neuromodulation technologies such as deep brain stimulation and optogenetics have transformed the treatment of neurological disorders by enabling targeted control of dysfunctional neural circuits, yet their clinical adoption is limited by invasive surgical requirements, off-target effects, poor penetration depth, and lack of cell-type specificity....
|
|
Engineered T-cell receptor platforms for targeted detection and treatment of cytomegalovirus-infected cells
This technology uses highly engineered T-cell receptors to precisely detect and target cytomegalovirus-infected cells, offering improved therapies and diagnostics by enhancing binding strength, stability, and resistance to viral immune evasion.
Background
Cytomegalovirus (CMV) is a widespread herpesvirus that poses significant health risks, particularly...
|
|
Antibody compositions for improving detection and treatment of Bacillus anthracis infections
This technology uses specially designed antibodies with enhanced ability to detect or treat Bacillus anthracis infections, improving both diagnosis and therapy for anthrax.
Background
Bacillus anthracis, the causative agent of anthrax, is a highly virulent bacterium that poses significant threats to both public health and national security. Anthrax...
|
|
Covalent ERK inhibitors for suppressing cancer
BI-78D3, a small molecule, covalently binds to ERK1/2’s D-recruitment site, disrupting ERK signaling crucial for cancer cell growth. This shows promise for treating ERK-dependent cancers, including those resistant to BRAF inhibitors.
This disrupts ERK signaling crucial for cell proliferation and survival, particularly in certain cancers like...
|
|
Lipid nanocarriers for promoting angiogenesis
This invention describes a new way to deliver a protein called transmembrane stem cell factor (tmSCF) using tiny carriers made of lipids (fats). This helps promote the growth of new blood vessels and could treat peripheral vascular disease.
Background
Peripheral vascular disease (PVD) affects a significant portion of the aging population, often leading...
|
|
Cellulose nanofiber spray for enhanced filtration efficiency
This invention is a water-soluble, biodegradable, and biocompatible spray composed of cellulose nanofibers and polyvinyl alcohol that enhances the filtration efficiency of textiles by creating a protective layer that can break the membranes of pathogens.
Background
The need for effective filtration systems, particularly in personal protective equipment...
|
|
Multifunctional iron chelators to combat antibiotic resistance and enable bacterial imaging
Deferasirox derivatives, such as ExPh and ExBT, are designed to chelate iron and inhibit antibiotic-resistant bacteria like MRSA and VRE. They exhibit unique fluorescent properties for bacterial imaging, offering both therapeutic and diagnostic capabilities.
Background
Antibiotic resistance is a growing public health concern, driven by the rapid evolution...
|
|
First-in-class blood-based diagnostic panel for depression and suicide risk
Background
The instinct to stay alive and maintain well-being is fundamental to all of us, yet nearly a million lives are lost to suicide each year around the world, presenting a significant public health challenge. Despite ongoing efforts, effectively identifying the risk and preventing suicide remains a complex issue. Biologically, suicide often...
|
|
Patient-specific prostate cancer progression prediction model to inform personalized treatment
Problem
Prostate cancer is a significant health problem worldwide, and there is a vital need for accurate predictive models of disease progression to aid in effective treatment planning. Current models are largely statistical, based on a population of patients, and neglect the patient’s unique attributes. There is a significant need for more...
|
